Cingulate (NASDAQ:CING) PT Raised to $8.00 at HC Wainwright

Cingulate (NASDAQ:CING – Free Report) had its price objective boosted by HC Wainwright to $8.00 in a research note released on Friday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. Several other analysts also recently commented on CING. Laidlaw downgraded shares of Cingulate from a buy rating to a hold […]

Related Keywords

, Maxim Group , Hightower Advisors , Cingulate Inc , Geode Capital Management , Renaissance Technologies , Laidlaw , Cingulate Company Profile , Free Report , Trading Down , Get Free Report , Capital Management , Street Corp , Tower Advisors , Creative Planning , Cingulate Daily , Cingulate , Nasdaq Cing , Icing , Medical , Boost Price Target , Hc Wainwright ,